NTBLQ (Notable Labs) ROA %: -156.95% (As of Jun. 2024)


What is Notable Labs ROA %?

Notable Labs NTBLQ -90.00% ROA % is -156.95% as of Jun. 2024.

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Notable Labs's annualized Net Income for the quarter that ended in Jun. 2024 was $-20.88 Mil. Notable Labs's average Total Assets over the quarter that ended in Jun. 2024 was $13.30 Mil. Therefore, Notable Labs's annualized ROA % for the quarter that ended in Jun. 2024 was -156.95%.

The historical rank and industry rank for Notable Labs's ROA % or its related term are showing as below:

NTBLQ's ROA % is not ranked *
in the Biotechnology industry.
Industry Median: -32.87
* Ranked among companies with meaningful ROA % only.

Notable Labs  (OTCPK:NTBLQ) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=-20.876/13.301
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-20.876 / 0.008)*(0.008 / 13.301)
=Net Margin %*Asset Turnover
=-260950 %*0.0006
=-156.95 %

Note: The Net Income data used here is four times the quarterly (Jun. 2024) net income data. The Revenue data used here is four times the quarterly (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Notable Labs ROA % Related Terms


Notable Labs ROA % Historical Data

* Premium members only.

The historical data trend for Notable Labs's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Notable Labs ROA % Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
ROA %
-189.11 -205.83 -89.92

Notable Labs Quarterly Data
Dec21 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
ROA % Get a 7-Day Free Trial -455.23 0.00 0.00 -85.74 -156.95

NTBLQ vs VRTX, REGN, ALNY: ROA % Comparison

For the Biotechnology subindustry, Notable Labs's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Notable Labs ROA % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's ROA % distribution charts can be found below:

* The bar in red indicates where Notable Labs's ROA % falls into.



Notable Labs ROA % Calculation

Notable Labs's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-11.264/( (5.511+19.541)/ 2 )
=-11.264/12.526
=-89.92 %

Notable Labs's annualized ROA % for the quarter that ended in Jun. 2024 is calculated as:

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Jun. 2024 ))/ count )
=-20.876/( (15.598+11.004)/ 2 )
=-20.876/13.301
=-156.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Jun. 2024) net income data. ROA % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROA % →
What does a ROA % of -156.95% mean?
Notable Labs (NTBLQ) has a ROA % of -156.95% as of Jun. 2024. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Notable Labs and its competitors.
Is Notable Labs' ROA % too high?
Notable Labs' current ROA % is -156.95%.
How does Notable Labs' ROA % compare to VRTX and REGN?
Notable Labs' ROA % of -156.95% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Biotechnology company?
A good ROA % depends on the Biotechnology industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Notable Labs and its competitors. Notable Labs's current ROA % is -156.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Notable Labs stock overvalued right now?
Notable Labs (NTBLQ) has a current ROA % of -156.95%. The current ROA % is -156.95%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Notable Labs (NTBLQ), the current ROA % is -156.95% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Notable Labs Business Description

Address 320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.